User contributions for Abdurahman Khalil

For Abdurahman Khalil talk block log uploads logs

Jump to navigation Jump to search

This user is currently blocked. The latest block log entry is provided below for reference:

20:53, 6 April 2014 Gerald Chi talk contribs changed block settings for Abdurahman Khalil talk contribs with an expiration time of indefinite (account creation disabled, autoblock disabled, email disabled)

18:1618:16, 12 March 2014 diff hist +17‎ Doxazosin description ‎No edit summary
18:1518:15, 12 March 2014 diff hist 0‎ Doxazosin overdosage ‎No edit summary
18:1518:15, 12 March 2014 diff hist 0‎ Doxazosin use in specific populations ‎No edit summary
18:1418:14, 12 March 2014 diff hist 0‎ Doxazosin adverse reactions ‎No edit summary
18:1418:14, 12 March 2014 diff hist +34‎ Doxazosin adverse reactions ‎No edit summary
18:1218:12, 12 March 2014 diff hist 0‎ Doxazosin warnings ‎No edit summary
18:1218:12, 12 March 2014 diff hist +4‎ Doxazosin dosage and administration ‎No edit summary
18:1118:11, 12 March 2014 diff hist +46‎ Doxazosin indications and usage ‎No edit summary
18:0618:06, 12 March 2014 diff hist +28‎ Doxazosin dosage and administration ‎No edit summary
18:0418:04, 12 March 2014 diff hist +23‎ N PDE-5 inhibitor ‎ ←Redirected page to Sildenafil
18:0218:02, 12 March 2014 diff hist 0‎ Doxazosin dosage and administration ‎No edit summary
18:0218:02, 12 March 2014 diff hist 0‎ Template:Mecamylamine ‎No edit summary current
17:5917:59, 12 March 2014 diff hist 0‎ Mecamylamine ‎No edit summary
17:5817:58, 12 March 2014 diff hist −117‎ Reserpine ‎No edit summary
17:5717:57, 12 March 2014 diff hist −24‎ Template:Reserpine ‎No edit summary current
17:5717:57, 12 March 2014 diff hist 0‎ Reserpine labels and packages ‎No edit summary
17:5617:56, 12 March 2014 diff hist 0‎ Reserpine patient counseling information ‎No edit summary
17:5617:56, 12 March 2014 diff hist 0‎ Reserpine how supplied storage and handling ‎No edit summary
17:5617:56, 12 March 2014 diff hist +27‎ Reserpine nonclinical toxicology ‎No edit summary
17:5517:55, 12 March 2014 diff hist 0‎ Reserpine clinical pharmacology ‎No edit summary
17:5517:55, 12 March 2014 diff hist +17‎ Reserpine description ‎No edit summary
17:5517:55, 12 March 2014 diff hist 0‎ Reserpine description ‎No edit summary
17:5517:55, 12 March 2014 diff hist 0‎ Reserpine overdosage ‎No edit summary
17:5417:54, 12 March 2014 diff hist +1,611‎ Reserpine use in specific populations ‎No edit summary
17:5417:54, 12 March 2014 diff hist +1,584‎ Reserpine precautions ‎No edit summary
17:5117:51, 12 March 2014 diff hist +821‎ Reserpine drug interactions ‎No edit summary
17:5017:50, 12 March 2014 diff hist 0‎ Reserpine adverse reactions ‎No edit summary
17:5017:50, 12 March 2014 diff hist 0‎ Reserpine precautions ‎No edit summary
17:5017:50, 12 March 2014 diff hist +8‎ Reserpine warnings ‎No edit summary
17:4917:49, 12 March 2014 diff hist 0‎ Reserpine warnings ‎No edit summary
17:4917:49, 12 March 2014 diff hist 0‎ Reserpine contraindications ‎No edit summary
17:4917:49, 12 March 2014 diff hist 0‎ Reserpine dosage and administration ‎No edit summary
17:4817:48, 12 March 2014 diff hist 0‎ Reserpine indications and usage ‎No edit summary
17:4817:48, 12 March 2014 diff hist 0‎ Mecamylamine labels and packages ‎No edit summary
17:4817:48, 12 March 2014 diff hist 0‎ Mecamylamine patient counseling information ‎No edit summary
17:4817:48, 12 March 2014 diff hist 0‎ Mecamylamine how supplied storage and handling ‎No edit summary
17:4717:47, 12 March 2014 diff hist −2‎ Mecamylamine nonclinical toxicology ‎No edit summary
17:4717:47, 12 March 2014 diff hist 0‎ Mecamylamine clinical pharmacology ‎No edit summary
17:4717:47, 12 March 2014 diff hist +17‎ Mecamylamine description ‎No edit summary
17:4617:46, 12 March 2014 diff hist 0‎ Mecamylamine use in specific populations ‎No edit summary
17:4617:46, 12 March 2014 diff hist 0‎ Mecamylamine drug interactions ‎No edit summary
17:4617:46, 12 March 2014 diff hist 0‎ Mecamylamine adverse reactions ‎No edit summary
17:4517:45, 12 March 2014 diff hist 0‎ Mecamylamine precautions ‎No edit summary
17:4517:45, 12 March 2014 diff hist 0‎ Mecamylamine warnings ‎No edit summary
17:4517:45, 12 March 2014 diff hist 0‎ Mecamylamine contraindications ‎No edit summary
17:4517:45, 12 March 2014 diff hist 0‎ Mecamylamine dosage and administration ‎No edit summary
17:4517:45, 12 March 2014 diff hist +4‎ Mecamylamine indications and usage ‎No edit summary
17:4417:44, 12 March 2014 diff hist 0‎ Mecamylamine overdosage ‎No edit summary

19:4619:46, 11 March 2014 diff hist 0‎ Methyldopa injection clinical pharmacology ‎No edit summary
19:4619:46, 11 March 2014 diff hist 0‎ Methyldopa injection description ‎No edit summary

Retrieved from "https://www.wikidoc.org/index.php/Special:Contributions/Abdurahman_Khalil"

Cookies help us deliver our services. By using our services, you agree to our use of cookies.